Recently, Shi Yuanyuan, Chairman of Shenzhen Cell Valley Group, led a core team to conduct research and exchange at the Central Hospital Affiliated to Shenyang Medical College. He held in-depth discussions with leading officials including Zhang ShaoHong , Deputy Director of the Administrative Committee of Shenyang Economic Development Zone, and Chen Zhenjun , Member of the Standing Committee of the Party Committee and Member of the University Council of Shenyang Medical College, as well as Secretary of the Party Committee of the Affiliated Central Hospital.The two sides focused on core topics such as the development of the life and health industry, the transformation of cell therapy technologies, and discipline construction. The discussion aimed to build a cross-regional cooperation bridge and empower the high-quality development of Shenyang's life and health cause.

At the symposium, Chairman Shi Yuanyuan gave a detailed introduction to the profile, development history, core products, technological advantages, market scale and national layout of Cell Valley Group.Shenzhen Cell Valley is the only enterprise in China with industrial-scale GMP production capacity for clinical-grade retroviral vectors. Its independently developed products have obtained a number of authoritative certifications, including China’s first DMF for retroviral vectors, the world’s first DMF for NK exosomes, and stem cell product certification from the National Institutes for Food and Drug Control.The company has carried out clinical research cooperation with more than 100 Class III Grade A hospitals nationwide, and has planned to jointly build regional cell preparation centers with a number of top-tier hospitals and local governments.Shi Yuanyuan noted that the hospital’s strong clinical foundation in multiple specialized disciplines is highly complementary to the company’s cutting-edge technology platforms and industrialization capabilities in cell therapy. The combination of both sides’ strengths is expected to jointly explore innovative clinical applications of cell therapy technologies and promote the innovative development of the life and health industry.

Zhang Shaohong, Deputy Director of the Administrative Committee of Shenyang Economic Development Zone, introduced the regional industrial development plan. She noted that while consolidating its traditional advantageous industries, Tiexi District is fully prioritizing biopharmaceuticals as a key development area. Shenyang International Life and Health City is a major project under the 15th Five-Year Plan of both Liaoning Province and Shenyang City.To foster new quality productive forces, the Development Zone has intensified investment promotion for biopharmaceuticals since December 2025. Shenzhen Cell Valley was selected as a key partner for its outstanding core R&D capabilities, advanced cell preparation technologies and high-level quality control.She expressed hope that Shenzhen Cell Valley will settle in Shenyang and work together with the hospital to jointly promote the rise of this innovation highland.

Chen Zhenjun, Secretary of the Party Committee of Central Hospital Affiliated to Shenyang Medical College, gave a detailed introduction to the hospital’s basic profile, disciplinary strengths and scientific research achievements, and expressed strong willingness to cooperate with Shenzhen Cell Valley Group in the life and health sector.He noted that the hospital boasts profound scientific research accumulation and clinical advantages in cell therapy, regenerative medicine and other fields, which are highly compatible with the technological strengths of Cell Valley Group, promising broad prospects for cooperation between the two sides.

This trip to Shenyang by Shenzhen Cell Valley Group is not only a key step in its national layout, but also a concrete initiative to respond to the national strategy of developing new-quality productive forces and promoting innovation in the biomedical industry.Taking this research visit as a starting point, Shenzhen Cell Valley will join hands with the Central Hospital Affiliated to Shenyang Medical College to jointly write a new chapter in the in-depth integration of industry, academia, research and medical treatment, contributing scientific and technological strength to the revitalization of medical and health services in Northeast China and safeguarding people’s life and health.

Central Hospital Affiliated to Shenyang Medical College

Central Hospital Affiliated to Shenyang Medical College (Shenyang Central Hospital, Shenyang Hand Surgery Hospital) was founded in 1956. It is a large comprehensive Class III Grade A hospital integrating medical treatment, teaching, scientific research, prevention, healthcare and rehabilitation.After 70 years of development, the hospital has formed a disciplinary system with distinctive strengths in traumatic surgery, hand, foot and ankle surgery, emergency care, respiratory and critical care medicine. Its hand surgery is an advanced discipline leading in Northeast China, first-class in China and up to international standards.As a regional medical center of comprehensive category in Liaoning Province, the hospital has 14 provincial-level key clinical specialties and 36 municipal-level key clinical specialties. It is also home to a number of national-level platforms, including a National Postdoctoral Research Station, a National Standardized Residency Training Base, a National Chest Pain Center and an Advanced Stroke Center.